Mr. Burns has served as President, CEO, and member of the Board of Directors of Glaukos since 2002. He has also served on the Board of DOSE Medical Corporation since 2009 and served as its CEO and President from 2010-2015. Mr. Burns has a proven record of building successful medical device and pharmaceutical businesses and creating successful new markets in ophthalmology. Mr. Burns has more than 25 years of direct ophthalmic management experience, including over 20 years of general management experience across a broad range of ophthalmic medical devices, ophthalmic pharmaceuticals, drug delivery technologies, surgical products, and over-the-counter products. Prior to joining Glaukos, Mr. Burns led Eyetech Pharmaceuticals, Inc. (acquired by OSI Pharmaceuticals, Inc.) as its President and COO and as a Director. From 1990-1997, Mr. Burns served as Sr. VP and General Manager of Chiron Vision Corporation (acquired by Bausch & Lomb) and then as VP Global Strategy and General Manager, refractive surgery, of Bausch & Lomb from 1998-2000. Mr. Burns has also served as entrepreneur in residence at Versant Ventures Management, LLC, and entity affiliated with one of Glaukos’ principal stockholders. Mr. Burns received a BA from Yale University.